Clinical Trials Update: May 19, 2006
Acne Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Huntington's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Are you interested in participating in a clinical trial for acne? Eligible volunteers must be 12 or older with facial acne vulgaris, characterized by at least five facial inflammatory or non-inflammatory lesions. Female candidates may not be pregnant and must practice a reliable method of contraception throughout the study.
The research site is in West Palm Beach, Fla.
Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
Novartis Pharmaceuticals Corp. is conducting a clinical research study for children 6-12 with Attention-Deficit/Hyperactivity Disorder (ADHD). The study will test the safety, tolerability and effectiveness of an investigational dosage of dexmethylphenidate HCl extended-release capsules, an already approved drug for ADHD. Children may not be home-schooled, or have a history of seizures, high blood pressure, or heart problems.
Research sites are located across the United States.
North Shore University Hospital is conducting a study to determine the safety, tolerability, and dosage of an experimental drug in people with Huntington's disease. Volunteers must be 18 and be able to walk, and will be excluded from participation if they are pregnant or breastfeeding, have evidence of unstable medical illness, clinically significant heart disease or lung disease, or have had an active peptic ulcer within 90 days of study start. Other criteria apply.
The research site is in Manhasset, N.Y.
Copyright 2006 CenterWatch. All rights reserved.